Bayer’s Adempas® receives ‘Highly Commended’ honour at 2014 Prix Galien Awards

Bayer HealthCare is delighted to announce that the innovative drug, Adempas, has received a Prix Galien Award – a High Commendation at the 2014 ceremony at The House of Commons. The bi-annual awards are designed to recognise the significant contribution the pharmaceutical industry makes in clinical research and drug development.
Source: Pharmacy Europe - Category: Drugs & Pharmacology Authors: Tags: *** Editor's Pick European Conferences and Symposia Practical therapeutics Cost effectiveness Industry News Drug development CTEPH health outcomes Latest News pah riociguat SCG enzyme Source Type: news